These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9413952)

  • 21. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
    Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
    Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boron neutron capture therapy: a guide to the understanding of the pathogenesis of late radiation damage to the rat spinal cord.
    Morris GM; Coderre JA; Whitehouse EM; Micca P; Hopewell JW
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1107-12. PubMed ID: 8175395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
    Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
    Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine.
    Coderre JA; Joel DD; Micca PL; Nawrocky MM; Slatkin DN
    Radiat Res; 1992 Mar; 129(3):290-6. PubMed ID: 1542717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
    Coderre JA; Elowitz EH; Chadha M; Bergland R; Capala J; Joel DD; Liu HB; Slatkin DN; Chanana AD
    J Neurooncol; 1997 May; 33(1-2):141-52. PubMed ID: 9151231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of boron neutron capture irradiation on oral mucosa: evaluation using a rat tongue model.
    Coderre JA; Morris GM; Kalef-Ezra J; Micca PL; Ma R; Youngs K; Gordon CR
    Radiat Res; 1999 Aug; 152(2):113-8. PubMed ID: 10409319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boron neutron capture therapy: effects of split dose and overall treatment time.
    Morris GM; Micca PL; Rezvani M; Hopewell JW; Coderre JA
    J Neurooncol; 2001 Apr; 52(2):101-10. PubMed ID: 11508809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capillary electrophoresis-electrospray mass spectrometry and HR-ICP-MS for the detection and quantification of 10B-boronophenylalanine (10B-BPA) used in boron neutron capture therapy.
    Pitois A; de las Heras LA; Zampolli A; Menichetti L; Carlos R; Lazzerini G; Cionini L; Salvatori PA; Betti M
    Anal Bioanal Chem; 2006 Feb; 384(3):751-60. PubMed ID: 16372182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boron neutron capture irradiation of the rat spinal cord: histopathological evidence of a vascular-mediated pathogenesis.
    Morris GM; Coderre JA; Bywaters A; Whitehouse E; Hopewell JW
    Radiat Res; 1996 Sep; 146(3):313-20. PubMed ID: 8752310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teatment planning figures of merit in thermal and epithermal boron neutron capture therapy of brain tumours.
    Wallace SA; Mathur JN; Allen BJ
    Phys Med Biol; 1994 May; 39(5):897-906. PubMed ID: 15552092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of BPA-BNCT on normal bone: determination of the CBE value in miceā€”.
    Iwasaki R; Yoshikawa R; Umeno R; Seki A; Matsukawa T; Takeno S; Yokoyama K; Mori T; Suzuki M; Ono K
    J Radiat Res; 2023 Sep; 64(5):795-803. PubMed ID: 37517393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boron neutron capture therapy: re-irradiation response of the rat spinal cord.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Wielopolski L
    Radiother Oncol; 1998 Sep; 48(3):313-7. PubMed ID: 9925251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma.
    Fukuda H; Honda C; Wadabayashi N; Kobayashi T; Yoshino K; Hiratsuka J; Takahashi J; Akaizawa T; Abe Y; Ichihashi M; Mishima Y
    Melanoma Res; 1999 Feb; 9(1):75-83. PubMed ID: 10338337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porphyrin-mediated boron neutron capture therapy: evaluation of the reactions of skin and central nervous system.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Nawrocky M; Miura M
    Int J Radiat Biol; 2003 Mar; 79(3):149-58. PubMed ID: 12745879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
    Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
    BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative assessment of single-dose and fractionated boron neutron capture therapy.
    Coderre JA; Morris GM; Micca PL; Fisher CD; Ross GA
    Radiat Res; 1995 Dec; 144(3):310-7. PubMed ID: 7494875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.